Compliance and persistence should be an integral part of clinical (observational) studies and pharmacoeconomic analyses in order to estimate the cost–effectiveness of drug therapies in current ...

This article emphasizes the importance of integrating medication compliance and persistence into pharmacoeconomic evaluations, using osteoporosis as an example. A limited number of studies carried ...